Differential diagnosis of eosinophilic chronic rhinosinusitis

Current Allergy and Asthma Reports

Volumn 6, Issue 3, 2006, Pages 203-214

  Sok, John C ^b   Ferguson, Berrylin J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCINEURIN INHIBITOR; CYTOKINE; HLA ANTIGEN CLASS 2; IBUPROFEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONTELUKAST; MUCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE; PIMECROLIMUS; PLACEBO; PROSTAGLANDIN E2; PSEUDOMONIC ACID; STEROID; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ALLERGY TEST; ALTERNARIA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIGEN PRESENTING CELL; ARTICLE; ASPERGILLUS; CELL INFILTRATION; CLADOSPORIUM; COMPUTER ASSISTED TOMOGRAPHY; DESENSITIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG TARGETING; ENZYME INHIBITION; EOSINOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOMODULATION; LAVAGE; MOUSE; NONHUMAN; NOSE SURGERY; PARANASAL SINUS DISEASE; PATHOPHYSIOLOGY; RECEPTOR BINDING; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; TH2 CELL; TREATMENT OUTCOME;

ANIMALS; ASPIRIN; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FUNGI; HUMANS; HYPERSENSITIVITY; RHINITIS; SINUSITIS;

EID: 33745675671     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0036-1     Document Type: Article

References (61)

1. Benninger MS, Ferguson BJ, Hadley JA, et al.: Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129 (Suppl):S1-S32.
2. Lethbridge-Cxejku M, Schiller JS, Bernadel L: Summary health statistics for U.S. adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 2004, 10:222.
3. Bajracharya H, Hinthorn D: Sinusitis, Chronic. http://www.emedicine.com/med/topic2556.htm. Accessed November 2005.
4. Meltzer EO, Hamilos DL, Hadley JA, et al.: Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004, 114(6 Suppl):155-212.
5. Newman LJ, Platts-Mills TA, Phillips CD, et al.: Chronic sinusitis: relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994, 271:363-367.
6. Hoover GE, Newman Q, Platts-Mills TA, et al.: Chronic sinusitis: risk factors for extensive disease. J Allergy Clin Immunol 1997, 100:185-191.
7. Szucs E, Ravandi S, Goossens A, et al.: Eosinophilia in the ethmoid mucosa and its relationship to the severity of inflammation in chronic rhinosinusitis. Am J Rhinol 2002, 16:131-134.
8. Baroody FM, Hughes CA, McDowell P, et al.: Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg 1995, 121:1396-402.
9. Sobol SE, Fukakusa M, Christodoulopoulos P, et al.: inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 2003, 113:410-414.
10. Chan KH, Abzug MJ, Coffinet L, et al.: Chronic rhinosinusitis in young children differs from adults: a histopathology study. J Pediatr 2004, 144:206-212.
11. Zadeh MH, Banthia V, Anand VK, et al.: Significance of eosinophilia in chronic rhinosinusitis. Am J Rhinol 2002, 16:313-317.
12. Alam R, Busse WW: The eosinophil - quovadis? J Allergy Clin Immunol 2004, 113:38-42.
13. Bochner BS: Verdict in the case of therapies versus eosinophils: the jury is still out. J Allergy Clin Immunol 2004, 113:3-9.
14. Dunnill MS: Pulmonary fibrosis. Histopathology 1990, 16:321-329.
15. Weller PF: Human eosinophils. J Allergy Clin Immunol 1997, 100:283-287.
16. Ebisawa M, Schleimer RP, Bickel C, et al.: Phenotyping of purified human peripheral blood eosinophils using the blind panel mAb. In Leukocyte Typing V: White Cell Differentiation Antigens; Edited by Schlossman S, Boumsell L, Gilks W, et al. New York, NY: Oxford University Press; 1995:1036-1038.
17. Temple R, Allen E, Fordham J, et al.: Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am J Respir Cell Mol Biol 2001, 25:425-433.
18. Tachimoto H, Bochner BS: The surface phenotype of human eosinophils. Chem Immunol 2000, 76:45-62.
19. Leckie MJ, Brinke A, Khan J, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356:2144-2148.
20. O'Byrne PM, Inman MD, Parameswaran K: The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 2001, 108:503-508.
21. Liu LY, Sedgwick JB, Bates ME, et al.: Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 2002, 169:6452-6458.
22. Mattes J, Yang M, Mahalingam S, et al.: Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002, 195:1433-44.
23. Lee JJ, Dimina D, Macias MP, et al.: Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004, 305:1773-1776.
24. Irwin MJ, Hudson KR, Fraser JD, et al.: Enterotoxin residues determining T-cell receptor V binding specificity. Nature 1992, 359:841-843.
25. Schubert MS: A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001, 87:181-188.
26. Schubert MS, Hutcheson PS, Graff RJ, et al.: HLA-DQB1 *03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J Allergy Clin Immunol 2004, 114:1376-1383.
27. Bernstein JM, Ballow M, Schlievert PM, et al.: A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003, 17:321-326.
28. Bernstein JM, Kansal R: Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2005, 13:39-44.
29. Seiberling KA, Conley DB, Tripathi A, et al.: Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005, 115:1580-1585.
30. Bachert C, Gevaert P, Holtappels G, et al.: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001, 107:607-614.
31. Zhang N, Gevaert P, van Zele T, et al.: An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 2005, 43:162-168.
32. Hendricks A, Leibold W, Kaever V, et al.: Prostaglandin E2 is variably induced by bacterial superantigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response. Immunobiology 2000, 201:493-505.
33. Desouza IA, Franco-Penteado CF, Camargo EA, et al.: Inflammatory mechanisms underlying the rat pulmonary neutrophil influx induced by airway exposure to staphylococcal enterotoxin type A. Br J Pharmacol 2005, 146:781-791.
34. Casale TB, Condemi J, LaForce C, et al.: Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001, 286:2956-2967.
35. Chiang DT, Clark J, Casale TB: Omalizumab in asthma: approval and postapproval experience. Clin Rev Allergy Immunol 2005, 29:3-16.
36. National Institutes of Health: Xolair in Patients with Chronic Sinusitis. http://clinicaltrials.gov/show/NCT00117611. Accessed November 2005.
37. Katsuyama M, Ichikawa H, Ogawa S, et al.: A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 2005, 38:197-205.
38. Ferguson BJ, Stolz DB: Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 2005, 19:452-457.
39. Marple BF: Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001, 111:1006-1019.
40. Manning S, Mabry R, Schaefer S, et al.: Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope 1993, 103:717-721.
41. Collins M, Nair S, Smith W, et al.: Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004, 114:1242-1246.
42. Pant H, Kette FE, Smith WB, et al.: Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005, 115:601-606.
43. Schubert MS: Antileukotriene therapy for allergic fungal sinusitis. J Allergy Clin Immunol 2001, 108:466-467.
44. Stevens DA, Schwartz HJ, Lee JY, et al.: A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000, 342:756-762.
45. Bassichis BA, Marple BF, Mabry RL, et al.: Use of immunotherapy and previously treated patients with allergic fungal Sinusitis. Otolaryngol Head Neck Surg 2001, 125:487-490.
46. Marple B, Newcomer M, Schwade N, et al.: Natural history of allergic fungal rhinosinusitis: a 4- to 10-year follow-up. Otolaryngol Head Neck Surg 2002, 127:361-366.
47. Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 515:18-21.
48. Shin SH, Ponikau JU, Sherris DA, et al.: Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004, 114:1369-1375.
49. Braun H, Buzina W, Freudenschuss K, et al.: Eosinophilic fungal rhinosinusitis: a common disorder in Europe? Laryngoscope 2003, 113:264-269.
50. Lebowitz RA, Waltzman MN, Jacobs J, et al.: Isolation of fungi by standard laboratory methods in patients with chronic rhinosinusitis. Laryngoscope 2002, 112:2189-2191.
51. Ferguson BJ: Eosinophilic mucin rhinosinusitis - a distinctive clinicopathological entity. Laryngoscope 2000, 110:799-813.
52. Ponikau J, Sherris D, Kita H, et al.: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002, 110:862-866.
53. Ricchetti A, Landis BN, Maffioli A, et al.: Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261-263.
54. Weschta M, Rimek D, Formanek M, et al.: Topical anti-fungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122-1128.
55. Ponikau JU, Sherris DA, Weaver A, et al.: Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blinded pilot trial. J Allergy Clin Immunol 2005, 115:125-131.
56. Widal MF, Abrani P, Lermoyez; J: Anaphylaxie et idiosyncrasie. Presse Med 1922, 30:189-192.
57. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003, 111:913-921.
58. Sousa AR, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1493-1499.
59. Kowalski ML, Ptasinska A, Jedrzejczak M, et al.: Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 2005, 60:1139-1145.
60. Lindsay RW, Slaughter T, Britton-Webb J, et al.: The development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg, In press.
61. Ferguson BJ: Commentary: The development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg, In press.